Catalyst Wire Dossier Catalyst Wire Dossier

Deferasirox oral

Deferasirox · Ascend Laboratories, LLC
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Deferasirox oral, covering 2020-07-14 to 2025-03-27. Get the full timeline:

Most recent: FDA Approved: DEFERASIROX ORAL — Supplemental Application (Ascend Laboratories, LLC)

See pricing